Insights

  • Date

  • Content Type

  • Reset

Article

Pooling Efforts to Drive Gene Therapies for Rare Diseases

20.01.22
By PHCBI

All PHC, Biomedical refrigerators and freezers are manufactured using world leading technology and specialist engineering to deliver products...
Read More

Blog

Accelerating development through manufacturing best practices

17.01.22

By Kate Coleman, MSc.

The journey to commercialization can be fraught with challenges for organizations...

Read More

Blog

The Promise of Converging Disruptive Technologies in Advanced Therapy Production

11.01.22

By Yasser El-Sherbini

Advanced therapeutic medicinal products (ATMPs), better known as cell and gene therapy (CGT) in the United States...

Read More

Article

Bringing Novel Therapies to Market: 5 Strategies for Success

10.01.22
By Christian K. Schneider, MD

Advanced therapy medicinal products (ATMPs) were making headlines long before SARS-CoV-2, the virus that causes...
Read More

Article

Five Strategies for Success in Bringing Novel Therapies to Market

10.01.22
By Christian K Schneider

Advanced therapy medicinal products (ATMPs), as they’re called in the European Union and the UK, or...
Read More

Article

Designing Vaccines: The Role of Artificial Intelligence and Digital Health, Part 2

16.12.21
By Aleksandra Nevmerzhitskaya

In BPI’s October 2021 issue, part one of this review introduced the concepts of machine learning (ML)...
Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more